Company Filing History:
Years Active: 2013-2019
Title: Innovations by Inventor Ying Feng in the Field of Pharmaceuticals
Introduction
Ying Feng, a skilled inventor located in Fremont, CA, has contributed significantly to the field of pharmaceuticals with a focus on innovative therapies targeting diseases associated with PTEN deficiency. Holding a total of three patents, his work has the potential to influence how certain medical conditions are treated.
Latest Patents
One of Ying Feng's most notable inventions includes a series of compounds identified as Dihydropyridophthalazinone inhibitors of poly(ADP-ribose) polymerase (PARP). These compounds are designed for use in treating diseases linked to a PTEN deficiency. The patents provide detailed descriptions of these compounds, including their chemical structures as defined in Formula (I) and Formula (II). The inhibitors target PARP activity, which is essential for developing pharmaceutical compositions aimed at addressing various diseases, disorders, and conditions that can be ameliorated through this inhibition.
Career Highlights
Throughout his career, Ying Feng has worked with prominent companies in the pharmaceutical industry, including Biomarin Pharmaceutical Inc. and Medivation Technologies, Inc. His experiences in these organizations have likely enhanced his expertise in drug development and innovation.
Collaborations
Ying Feng has collaborated with notable professionals in his field, including coworkers Daniel T. Chu and Bing Wang. These collaborations have contributed to the refinement and success of his research and inventions.
Conclusion
In summary, Ying Feng stands out as a notable inventor in the pharmaceutical landscape. His innovative patents, particularly in the area of treating PTEN deficiency-associated diseases, underscore his positive impact on healthcare. With ongoing work and collaboration in the field, Ying Feng's contributions are poised to advance the treatment options available for patients facing challenging medical conditions.